The company has very limited products in terms of the number of pyridine/pyridine-based products. The company manufactures pyridine and its basic derivative, paraquat. The product portfolio is very limited with the lack of pyridine based derivatives and intermediates. Considering all the factors, the overall product offering of the company is average. Source: Secondary Research and MarketsandMarkets Analysis